Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	221,792 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	185,018 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
R03AK07	SYMBICORT	B	Formoterol fumarate dihydrate - 9mcg/Inhalation, Budesonide - 320mcg/Inhalation		Inhalation powder	3,378,420 L.L
R03AK07	SYMBICORT	B	Formoterol fumarate dihydrate - 4.5mcg/Inhalation, Budesonide - 160mcg/Inhalation		Inhalation powder	3,378,420 L.L
R03AK07	SYMBICORT TURBUHALER	B	Formoterol fumarate dihydrate - 4.5mcg/inhalation, Budesonide - 160mcg/inhalation		Inhalation powder	1,689,210 L.L
N06CA02	SERNIL	G	Flupentixol - 0.5mg, Melitracen - 10mg		Tablet	1,003,402 L.L
J02AC01	STABILANOL	G	Fluconazole - 2mg/ml	2mg/ml	Injectable solution	1,291,789 L.L
J02AC01	STABILANOL	G	Fluconazole - 150mg	150mg	Capsule	264,637 L.L
J02AC01	STABILANOL	G	Fluconazole - 100mg	100mg	Capsule	1,432,331 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	18,264,981 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	17,079,643 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	L.L
G04CB01	STERIFINE 5	G	Finasteride - 5mg	5mg	Tablet, film coated	733,354 L.L
G04CB01	STERIBO	G	Finasteride - 1mg	1mg	Tablet, film coated	2,636,619 L.L
M04AA03	STABURIC	G	Febuxostat - 80mg	80mg	Tablet, film coated	1,355,489 L.L
M04AA03	STABURIC	G	Febuxostat - 40mg	40mg	Tablet, film coated	1,081,345 L.L
M04AA03	STABURIC	G	Febuxostat - 120mg	120mg	Tablet, film coated	1,420,889 L.L
A02BC05	SOLEZOL	G	Esomeprazole - 40mg	40mg	Injectable powder for solution	301,021 L.L
N06AX27	SPRAVATO	B	Esketamine - 28mg/device	28mg/device	Solution	25,122,440 L.L
N06AX27	SPRAVATO	B	Esketamine (HCl) - 28mg	28mg/device	Solution	66,978,978 L.L
N06AX27	SPRAVATO	B	Esketamine (HCl) - 28mg	28mg/device	Solution	44,561,381 L.L
N06AX27	SPRAVATO	B	Esketamine (HCl) - 28mg	28mg/device	Solution	25,122,440 L.L
D10AF02	SPOTEX	G	Erythromycin - 4%	4%	Gel	854,684 L.L
A10BD20	SYNJARDY	B	Empagliflozin - 5mg, Metformin HCl - 850mg	5mg/850mg	Tablet, film coated	3,287,711 L.L
A10BD20	SYNJARDY	B	Empagliflozin - 5mg, Metformin HCl - 1000mg	5mg/1000mg	Tablet, film coated	3,399,653 L.L
A10BD20	SYNJARDY	B	Empagliflozin - 12.5mg, Metformin HCl - 850mg	12.5mg/850mg	Tablet, film coated	3,287,711 L.L
A10BD20	SYNJARDY	B	Empagliflozin - 12.5mg, Metformin HCl - 1000mg	12.5mg/1000mg	Tablet, film coated	3,399,653 L.L
A10BD20	SYNJARDY	B	Empagliflozin - 12.5mg, Metformin HCl - 1000mg	12.5mg/1000mg	Tablet, film coated	3,399,653 L.L

...